T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.06B |
| 2 |
Amphenol
APH
|
$728M |
| 3 |
Advanced Micro Devices
AMD
|
$608M |
| 4 |
Zscaler
ZS
|
$517M |
| 5 |
Northrop Grumman
NOC
|
$479M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$1B |
| 2 |
Mastercard
MA
|
$809M |
| 3 |
Visa
V
|
$621M |
| 4 |
Fortinet
FTNT
|
$606M |
| 5 |
Thermo Fisher Scientific
TMO
|
$568M |
Sector Composition
| 1 | Technology | 27.6% |
| 2 | Healthcare | 20.51% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 11.2% |
| 5 | Financials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Braze
BRZE
$3.5B
| $2.28M | ﹤0.01% |
63,027
-2,630,330
| -98% | -$94.9M |
|
602
Neumora Therapeutics
NMRA
$272M
| $2.1M | ﹤0.01% |
2,103,029
-2,899,770
| -58% | -$2.9M |
|
603
Republic Services
RSG
$71.7B
| $1.97M | ﹤0.01% |
8,131
-32,318
| -80% | -$7.83M |
|
604
AppFolio
APPF
$10.2B
| $1.9M | ﹤0.01% |
8,639
-33
| -0.4% | -$7.26K |
|
605
Onto Innovation
ONTO
$5.1B
| $1.86M | ﹤0.01% |
15,345
-118,816
| -89% | -$14.4M |
|
606
Procter & Gamble
PG
$375B
| $1.81M | ﹤0.01% |
10,620
+3,126
| +42% | +$533K |
|
607
IonQ
IONQ
$12.4B
| $1.78M | ﹤0.01% |
+80,721
| New | +$1.78M |
|
608
Carpenter Technology
CRS
$12.3B
| $1.78M | ﹤0.01% |
9,794
-48,438
| -83% | -$8.78M |
|
609
Aaon
AAON
$6.62B
| $1.74M | ﹤0.01% |
22,314
-540,440
| -96% | -$42.2M |
|
610
Exxon Mobil
XOM
$466B
| $1.67M | ﹤0.01% |
14,036
+3,051
| +28% | +$363K |
|
611
Stryker
SYK
$150B
| $1.32M | ﹤0.01% |
3,532
+1,561
| +79% | +$581K |
|
612
Coca-Cola Consolidated
COKE
$10.5B
| $1.15M | ﹤0.01% |
8,490
-138,970
| -94% | -$18.8M |
|
613
Bank of America
BAC
$369B
| $1.1M | ﹤0.01% |
26,367
+1,861
| +8% | +$77.7K |
|
614
Apellis Pharmaceuticals
APLS
$3.55B
| $1.04M | ﹤0.01% |
47,713
| – | – |
|
615
Elevance Health
ELV
$70.6B
| $1.01M | ﹤0.01% |
2,321
+983
| +73% | +$428K |
|
616
Evergy
EVRG
$16.5B
| $1.01M | ﹤0.01% |
14,607
+8,998
| +160% | +$621K |
|
617
T-Mobile US
TMUS
$284B
| $984K | ﹤0.01% |
3,688
+432
| +13% | +$115K |
|
618
Colgate-Palmolive
CL
$68.8B
| $958K | ﹤0.01% |
10,218
+5,204
| +104% | +$488K |
|
619
O'Reilly Automotive
ORLY
$89B
| $940K | ﹤0.01% |
9,840
+4,095
| +71% | +$391K |
|
620
Illinois Tool Works
ITW
$77.6B
| $938K | ﹤0.01% |
3,780
+1,689
| +81% | +$419K |
|
621
Mondelez International
MDLZ
$79.9B
| $887K | ﹤0.01% |
13,071
+3,484
| +36% | +$236K |
|
622
HCA Healthcare
HCA
$98.5B
| $880K | ﹤0.01% |
2,546
+295
| +13% | +$102K |
|
623
CSX Corp
CSX
$60.6B
| $876K | ﹤0.01% |
29,746
-271,398
| -90% | -$7.99M |
|
624
Fiserv
FI
$73.4B
| $854K | ﹤0.01% |
3,863
+1
| +0% | +$221 |
|
625
EOG Resources
EOG
$64.4B
| $832K | ﹤0.01% |
6,482
+1,656
| +34% | +$213K |
|